|Type of business:||drug development, best known for migraine medication Treximet|
|CEO/US president:||John R. Plachetka|
Submitted by suestock on 06/16/2009 - 12:47
Want to post a comment?In order to join the conversation, you must be a member of newsobserver.com. Click here to register or to log in.